Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Gynecologic Oncology|November 17, 2015
Lymphopenia and its association with survival in patients with locally advanced cervical cancerEmily S Wu, Titilope Oduyebo, Lauren P Cobb, et al.
Obstetrics and Gynecology|December 10, 2015
Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost DisparityAmanda N Fader, R Matsuno Weise, Abdulrahman K Sinno, et al.
Obstetrics and Gynecology|August 9, 2016
Disparities in Surgical Care Among Women With Endometrial CancerDiana Mannschreck, Rayna K Matsuno, James P Moriarty, et al.
Gynecologic Oncology|July 26, 2020
Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort studyBritt K Erickson, Omar Najjar, Shari Damast, et al.
Gynecologic Oncology|April 18, 2018
Narcotics reduction, quality and safety in gynecologic oncology surgery in the first year of enhanced recovery after surgery protocol implementationJennifer E Bergstrom, Marla E Scott, Yewande Alimi, et al.
Gynecologic Oncology|August 22, 2018
Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinomaTing-Tai Yen, Tsutomu Miyamoto, Shiho Asaka, et al.
Clinical and Translational Medicine|July 31, 2024
Single-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancerChristine M O'Keefe, Yang Zhao, Leslie M Cope, et al.
Gynecologic Oncology|January 18, 2018
Minimally invasive hysterectomy surgery rates for endometrial cancer performed at National Comprehensive Cancer Network (NCCN) CentersJennifer Bergstrom, Alessia Aloisi, Shannon Armbruster, et al.
Gynecologic Oncology|September 26, 2016
Unplanned 30-day hospital readmission as a quality measure in gynecologic oncologyMaryAnn B Wilbur, Diana B Mannschreck, Ana M Angarita, et al.
Gynecologic Oncology|August 10, 2021
Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neuJoan Tymon-Rosario, Eric R Siegel, Stefania Bellone, et al.
Pageof 12